MIRAPEUTICS
LIVE

Serial Number

90879030

Owner

Flagship Labs 83, Inc.

Attorney

CHRISTINA M. LICURSI

Filing Date

Aug 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MIRAPEUTICS Trademark

Serial Number: 90879030

MIRAPEUTICS is a trademark filed by Flagship Labs 83, Inc. on August 12, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Flagship Labs 83, Inc. (5 trademarks)

Building 600/700, Suite 7-201
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

August 12, 2021

Registration Date

Not Registered

Published for Opposition

July 12, 2022

Goods & Services

protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, artificially produced peptides and proteins for use in the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, and fungal diseases and disorders; therapeutic pharmaceuticals, namely, artificially produced peptides and proteins for the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders, none of the foregoing pertaining to Parkinson's Disease or Restless Legs Syndrome

proteins for use in manufacture; proteins for industrial use in agriculture, aquaculture, cosmetics, consumer products and nutrition products

scientific research, pharmaceutical research, medical research; biotechnology research; technical scientific consultation and product development for others in the field of biotechnology and the development of protein-based pharmaceuticals, diagnostics, biomaterials, industrial reagents, agricultural products, cosmetics, consumer products and nutrition products

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2026 EXRA
SOU EXTENSION 4 GRANTED
Mar 31, 2026 EX4G
SOU EXTENSION 4 FILED
Mar 31, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 31, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2025 EXRA
SOU EXTENSION 3 GRANTED
Oct 21, 2025 EX3G
SOU EXTENSION 3 FILED
Oct 21, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 21, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 16, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 16, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 21, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 21, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 21, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 23, 2024 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Mar 13, 2024 TMBN
OPPOSITION TERMINATED NO. 999999
Mar 13, 2024 OP.T
OPPOSITION DISMISSED NO. 999999
Mar 13, 2024 OP.D
ASSIGNED TO EXAMINER
Jan 12, 2024 DOCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 22, 2023 ASCK
OPPOSITION INSTITUTED NO. 999999
Sep 8, 2022 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 8, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2022 CNRT
ASSIGNED TO EXAMINER
May 13, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2021 NWOS